CBSM phone app eases anxiety, depression in cancer patientsJune 23, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Huge underuse of germline testing for cancer patientsJune 22, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get medsJune 22, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Few of those eligible get lung cancer screening, despite USPSTF recommendationsJune 21, 2023OncologyLung Cancer
ACS officer provides ASCO highlights: Targeting hidden cancer, AI in oncologyJune 15, 2023Mixed TopicsBreast CancerMelanomaGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
Widespread carboplatin, cisplatin shortages: NCCN surveyJune 9, 2023Lung CancerBreast CancerGenitourinary CancerMixed TopicsLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid Cancers
Number of cancer survivors with functional limitations doubled in 20 yearsMay 11, 2023Lung CancerOncologyBreast CancerMixed TopicsLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid Cancers
